health-news

'Alzheimer's drug to be developed within five years'

Washington, Dec. 5 : Scientists have said that a drug that could provide a breakthrough for Alzheimer's disease will be available within the next five years.


Recruitment of people aged 55 - 90 to take part in the final-stage study in the US is taking place. The study will examine if the drug solanezumab slows the cognitive and functional decline of people who suffer from mild Alzheimer's.

In the new trial expected to end by December 2016, people are going to be given solanezumab as a monthly 400mg injection for 18 months.

Dr Eric Karran, director of research at Alzheimer's Research UK, said that the results would suggest that monthly injections should be given early to ward off the disease, News.com.au reported.

Dr Karran said that the drug showed "reasonable" effect in people suffering from mild Alzheimer's and results would come within five years.

--ANI (Posted on 05-12-2013)

health-news headlines

Cellulite facts worth knowing

Want to de-stress? Sex can help you

People are more concerned about their health at start of the week than weekends

Brain's anti-distraction system found

Chronic inflammation associated with aggressive prostate cancer

Easter chocolate can be good for health

'Smart' device that engineers cells to kill cancer

Lost stem cells are replaced by non-stem cells: Study

Brown fat breakthrough may be 'holy grail' of weight loss

Tuberculosis drug could also help treat other diseases

New method to fight Malaria drug resistance discovered

Dengue fever could soon be history

Quick Links: Goa | Munnar | Pondicherry | Free Yearly Horoscope '2014

Comments

Your e-mail:


Your Full Name:


Type verification image:
verification image, type it in the box

Message:

Back to Top